SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-016232
Filing Date
2019-08-09
Accepted
2019-08-09 16:03:52
Documents
72
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q prog20190630_10q.htm 10-Q 1310234
2 EXHIBIT 31.1 ex_152670.htm EX-31.1 11994
3 EXHIBIT 31.2 ex_152671.htm EX-31.2 11935
4 EXHIBIT 32 ex_152672.htm EX-32 7263
  Complete submission text file 0001437749-19-016232.txt   6626741

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pgnx-20190630.xml EX-101.INS 1619022
6 XBRL TAXONOMY EXTENSION SCHEMA pgnx-20190630.xsd EX-101.SCH 63016
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pgnx-20190630_cal.xml EX-101.CAL 48796
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pgnx-20190630_def.xml EX-101.DEF 371842
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pgnx-20190630_lab.xml EX-101.LAB 342928
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pgnx-20190630_pre.xml EX-101.PRE 407944
Mailing Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007 646-975-2500
PROGENICS PHARMACEUTICALS INC (Filer) CIK: 0000835887 (see all company filings)

IRS No.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23143 | Film No.: 191012965
SIC: 2834 Pharmaceutical Preparations